Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
September 30, 2026 -37.29M
June 30, 2026 21.30M
March 31, 2026 16.37M
December 31, 2025 16.26M
September 30, 2025 11.47M
June 30, 2025 15.30M
March 31, 2025 15.82M
December 31, 2024 26.66M
September 30, 2024 -0.008M
June 30, 2024 0.004M
March 31, 2024 -18.50M
December 31, 2023 10.23M
Date Value
September 30, 2023 6.571M
June 30, 2023 -22.26M
March 31, 2023 -99.39M
December 31, 2022 -1.858M
September 30, 2022 -4.266M
June 30, 2022 -0.129M
March 31, 2022 -0.146M
December 31, 2021 0.00
September 30, 2021
June 30, 2021
March 31, 2021
December 31, 2020 0.00

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Cypherpunk Technologies, Inc. -6.00M
Cue Biopharma, Inc. 0.00
Yarrow Bioscience, Inc. -5.00M
Faeth Therapeutics, Inc. 0.175M
Indaptus Therapeutics, Inc. 0.0882M